CD8A and neoplasm: The reduced relapse rate in patients who demonstrate a CD8+ T cell response directed against tumor antigens, coupled with the absence of chronic extensive GVHD, is consistent with the hypothesis that AZA has the capacity to epigenetically manipulate the alloreactive effect after transplantation.